IFCC & EFLM

New EFLM webinar: Updates on COVID-19 biology and diagnostics

By Dmitrii

Posted on May 24, 2020

EFLM e-learning

Darko Cerne, Chair of the EFLM WG Distance Education and e-Learning,
informs on next scheduled webinar and reminds that
the free access to EFLM webinars is reserved to EFLM Academy Members.Click here to know more about the EFLM Academy.

EFLM WEBINAR

Updates on COVID-19 biology and diagnostics

May 28, 2020

at h. 17.00 CET (duration 1 h)

Speaker: Giuseppe LIPPI (IT)

Moderator: Ana-Maria Simundic (HR)

Click here to register at the EFLM webinar

ABSTRACT : The novel coronavirus disease 2019 (COVID-19) is a pandemic infectious disease sustained by a member of the Coronaviridae family, finally called acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The human-to-human transmission is principally conveyed by droplets or physical contact with infected biological material. The range of clinical pictures is quite heterogeneous, with the vast majority of patients being asymptomatic or only experiencing mild respiratory symptoms. Nevertheless, in nearly 15% and 5% of all patients COVID-19 may progress towards severe or even critical illness, requiring sub-intensive or intensive care. The current death rate is comprised between 6-7%, but is highly variable worldwide depending on genetic, epigenetic and environmental factors. The etiological diagnosis of COVID-19 is, and will remain for long based on direct identification of viral RNA using molecular biology techniques in respiratory tracts samples (especially naso- and oro-pharyngeal swabs). Serological testing has also been recently developed, thus allowing to recognize that most COVID-19 patients develop an immune response against the virus, especially characterized by appearance of IgG and IgA anti-SARS-CoV-2 immunoglobulins one to two weeks after symptoms onset. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies has also recently emerged as a valid opportunity for epidemiologic surveillance, though a number of clear quality criteria will need to be fulfilled before any commercially available assay could be safely introduced into clinical practice.

ABOUT THE SPEAKER :

Giuseppe Lippi currently serves as Full Professor of Clinical Biochemistry and Molecular Biology at the University of Verona (Italy) and Director of the Clinical Chemistry and Haematology Laboratories of the University Hospital of Verona (Italy). He has published over 1700 articles in peer-reviewed journals, his total Impact Factor is over 6650 and the Hirsch Index (H-index) is 93. He has participated to more than 600 national and international congresses and has given more than 280 lectures to national and international meetings. In 2017 he has been appointed as Secretary of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Recently he has also been appointed as Chair of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19. Giuseppe Lippi is Editor in Chief of “Annals of Translational Medicine” and “Journal of Laboratory and Precision Medicine” and also serves as Associate Editor of the journals “Clinical Chemistry and Laboratory Medicine”, “Seminars in Thrombosis and Hemostasis” and “Diagnosis”, is the National Representative of the Italian Society of Clinical Biochemistry and Laboratory Medicine (SIBioC) and expert/consultant in the EFLM Working Group on Preanalytical Variability (WG-PRE).

European Federation of Clinical Chemistry and Laboratory Medicine

Operative Office:
Via Farini 81, 20159, Milan IT
Legal address:
Egmontstraat 11, 1000, Brussels BE

ACCLMU

New EFLM webinar: Updates on COVID-19 biology and diagnostics

Leave a Reply

Most Popular

Invitations to participate in a joint Congress and EFLM UEMS 21-24 September 2016 in Warsaw

Textbook “Clinical Biochemistry” 2013 Section 1

Proposal for publication of abstracts

Scientific & Practical Conference “Actual Issues of Laboratory Medicine”

Features of quality control of laboratory tests using test systems made by CJSC Vector-Best

Presentations at the Scientific & practical conference with international participation “DSTU EN ISO 15189:2015 – Roadmap to Quality of Laboratory Tests” (19-20 October 2016)

The concept of implementation of ISO EN ISO 15189 into the practice of medical laboratories of Ukraine

IFCC membership survey

Modern requirements to the accuracy of clinical laboratory studies and proposals for their establishment in Ukraine. (Assoc. Prof. Protsenko V.N., Ivkov A.G.)

The implementation of the quality management into practice of the medical laboratories